2022 West Lake Forum Held Guangyuyuan Wins Many Awards
Release time: 2022-07-04 10:38:57
|< /p>
Source: China Net Health
|
Editor in charge: Zhang Feng
< p>
On June 27th, the 2022 Great Health Industry West Lake Forum opened at the Wuzhen Internet International Convention and Exhibition Center. As a time-honored Chinese brand that has been inherited for nearly 500 years, Guangyuyuan has won the “Most Popular Corporate Brand”, “The Most Popular Star Single Product in Pharmacies”, “West Lake Award-China Pharmaceutical Industry Pioneer Award”, “Marketing Case Award”, “West Lake Award” The forum has won six awards of “VIP Strategic Cooperation” and “West Lake Ten-Year Moisture Award”, becoming one of the most concerned brands in the forum.
This is the industry’s affirmation of Guangyuyuan’s contribution to the revival of traditional Chinese medicine and the development of general health. Guangyuyuan said that it will continue to Join hands with colleagues in all pharmaceutical companies to jointly promote the development of traditional Chinese medicine and the big health industry.
Maintaining integrity and innovation, high-quality products attracting wide reputation and sustainable high-quality traditional Chinese medicine strategy
p>
Quality is the foundation of the brand, and Guangyuyuan takes into account “honesty” and “innovation”, quality traction, comprehensive layout, Continue the strategy of “creating high-quality traditional Chinese medicine throughout the industry chain”.
Authentic medicinal materials, concocted in ancient ways. Inheriting the essence is the core competitiveness of Guangyuyuan.
Guangyuyuan’s core products have become carriers of traditional Chinese medicine that inherit the essence of traditional Chinese medicine culture. The production process of Guilingji and Dingkundan It is listed as a national secret technology; the production skills of Guilingji, Dingkundan and An Gong Niuhuang Pill have been listed in the national intangible cultural heritage list.
In addition, in the selection of medicinal materials, Guangyuyuan has formulated strict varieties and territorial screening standards, and established rare medicinal materials planting and breeding bases all over the country. , to ensure the high quality of the medicinal materials used.
Inherit the essence and base on innovation. Guangyuyuan promotes the strategy of high-quality traditional Chinese medicine with “scientific research and innovation”: through the management policy of “production, education and research”, focusing on the transformation of dosage forms, process improvement, pharmacological efficacy and quality standards of core products, it actively promotes cooperation with universities, research institutes, R&D cooperation with hospitals and other institutions.
At the same time, Guangyuyuan uses modern scientific methods to carry out a number of multi-center evidence-based medical research and related basic research around core products to promote China Medicine is in line with modern medicine. Relevant research results have been published in well-known journals at home and abroad. Dingkundan, Guilingji and other products have been cited and recommended by many academic works, creating a precedent for Chinese medicine companies to deeply participate in clinical research. Nearly 200 related reports have been published, of which more than 10 papers have been included in SCI journals, which have been highly recognized by the industry and outside the industry.
In addition, Guangyuyuan conducts research on the chemical composition of traditional Chinese medicine preparations for the classic prescriptions, and establishes a traditional Chinese medicine fingerprint for the traditional Chinese medicine preparations produced, thereby More scientifically and accurately evaluate and control the overall quality of traditional classic prescription products.
As a time-honored traditional Chinese medicine company with a history of nearly 500 years, Guangyuyuan is constantly walking on the road of integrity and innovation. Its carefully crafted high-quality traditional Chinese medicines have been recognized by the market and established the brand value of “high-quality traditional Chinese medicine leaders”.
Long-term, healthy, sustainable and far-reaching reputation to write a new chapter of development
p>
2022 is a critical year for the revival of the Chinese medicine industry. The “14th Five-Year Plan for the Development of Traditional Chinese Medicine” issued by the General Office of the State Council is the first time that the five-year development plan of the traditional Chinese medicine industry has been issued by the General Office of the State Council since the founding of the People’s Republic of China, marking that the development of traditional Chinese medicine has been included in the historical process as an important strategy. .
Under the great changes unseen in a century, Guangyuyuan is also meeting its own new changes.
Guangyuyuan will return to Shanxi State-owned Assets in July 2021, and will be taken over by Shennong Technology, a large state-owned agricultural technology enterprise in Shanxi Province. Yuyuan’s long-term healthy and sustainable development provides solid support and broad space.
In the new development plan of the brand, Guangyuyuan unswervingly implements the development strategy of “creating high-quality traditional Chinese medicine in the whole industry chain”, Adhere to the mission and vision of “high-quality Chinese medicine leader”, and keep an open and inclusive attitude and concept in terms of market outlook, brand outlook, service outlook, quality outlook, talent outlook, moral outlook, management outlook, and environmental outlook. In the new era, we will make a new expression of the gene of Guangyuyuan, and strive to write the revitalization of Guangyuyuan into the chapter of the revitalization of the traditional Chinese medicine industry and the great rejuvenation of the Chinese nation.
Extended reading
[Source: China Net Health]
Disclaimer: This article is reproduced for the purpose of conveying more information. If the source is incorrectly marked or infringes your legal rights, please contact the author with the ownership certificate, we will correct or delete it in time, thank you. Email address: [email protected]